Reditus offering new test for bladder cancer
Reditus Laboratories is starting to use a bladder cancer test that is more sensitive and specific than other tests for the disease. UroVysion is a fluorescence in situ hybridization (FISH) assay developed for the detection of bladder cancer in urine specimens. UroVysion detects urinary cells that have chromosomal abnormalities consistent with bladder cancer. “It’s used […]